Emerging Trends to Drive Liver Cancer Diagnostics Market Growth at 7.4% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Liver Cancer Diagnostics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for liver cancer diagnostics has seen robust growth. It's projected to escalate from $9.69 billion in 2024 to $10.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors driving this growth during the historical period were advancements in biopsy methods and histopathology, the emergence of biomarker detection, the evolution of screening programs, progression in genetic testing, and enhancements in liver imaging modalities.

How Will the Liver Cancer Diagnostics Market Size Evolve and Grow by 2029?
Anticipated to experience robust growth in the coming years, the liver cancer diagnostics market is projected to reach a value of "$13.86 billion by 2029, with an annual compound growth rate (CAGR) of 7.4%. This expected growth during the forecast period is attributed to regulatory modifications and standardization, the escalating significance of imaging modalities, the emergence of next-generation sequencing, the expansion of screening programs and awareness, and the rising demand for biomarker-based tests. Key trends identified for this period include the increasing incidence and prevalence of liver cancer, progress in imaging technologies, an emphasis on non-invasive diagnostics, personalized medicine and diagnostics, and the incorporation of artificial intelligence (AI).

View the full report here:
https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

What Drivers Are Propelling the Growth of Liver Cancer Diagnostics Market Forward?
Increased instances of liver cancer are anticipated to stimulate the expansion of the liver cancer diagnostics market. The threat to life posed by liver cancer, a disease characterized by uncontrollable growth and multiplication of liver cells, necessitates diagnostic tests. Such tests ascertain whether cancer cells are proliferating within or around the liver following the original carcinoma diagnosis, thereby fueling the rise of the liver cancer diagnostics market. As an example, the Cancer Facts & Figures 2023 report, released by the American Cancer Society in January 2023, highlighted that new cases of liver and intrahepatic bile duct cancer in females had climbed from 12,640 in 2020 to 13,230 in 2023 within the US. Moreover, 2023 is projected to witness the diagnosis of 41,210 new liver cancer cases and an estimated 29,380 fatalities due to the disease in the US. Thus, the escalating incidence of liver cancer is steering the growth of the liver cancer diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10481&type=smp

Which Emerging Trends Are Transforming the Liver Cancer Diagnostics Market in 2025?
The liver cancer diagnostics market is evolving with the introduction of biomarker-based technologies for better detection. In November 2023, Roche Diagnostics, a US-based biotech company, launched the Elecsys PIVKA-II assay and GAAD algorithm to improve early identification of hepatocellular carcinoma by analyzing key biomarkers in high-risk patients.

What Are the Key Segments in the Liver Cancer Diagnostics Market?
The liver cancer diagnostics market covered in this report is segmented -

1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types
2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings
3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories

Subsegments:
1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma
2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma
3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma
4) Other Types: Secondary Liver Cancer, Fibrolamellar Carcinoma

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10481&type=smp

Who Are the Key Players Shaping the Liver Cancer Diagnostics Market's Competitive Landscape?
Major companies operating in the liver cancer diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen NV, Thermo Fisher Scientific Inc., Siemens Healthineers, Illumina Inc., Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc., Danaher Corporation, Foundation Medicine Inc., Agilent Technologies Inc., Genemed Biotechnologies Inc., Merck KGaA, Fujifilm Medical Systems USA Inc., GE Healthcare, Advanced Cell Diagnostics Inc., Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon A/S, BioGenex Laboratories Inc., OncoCyte Corporation, Guardant Health Inc., Exact Sciences Corporation, Grail Inc., Freenome Holdings Inc., Natera Inc., Personal Genome Diagnostics Inc., Thrive Earlier Detection Corp

What Geographic Markets Are Powering Growth in the Liver Cancer Diagnostics Market?
North America was the largest region in the liver cancer diagnostics market in 2024. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10481

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.